Genus plc

Genus plc

Type	Public
Traded as	LSE: GNS
Industry	Biotechnology
Founded	1933
Headquarters	Basingstoke, Hampshire, UK
Key people	Bob Lawson, Chairman[1] Karim Bitar, CEO[1]
Revenue	£398.5 million (2015)[2]
Operating income	£59.5 million (2015)[2]
Net income	£40.5 million (2015)[2]
Website	www.genusplc.com

Genus plc is a British-based business selling products manufactured using biotechnology to cattle and pig farmers. It is headquartered in Basingstoke and is a constituent of the FTSE 250 Index.

History

The business has its origins in the former Breeding & Production Division of the Milk Marketing Board which was established in 1933 and broken up in 1994.^[3] In 1999 Genus acquired ABS Global, a company founded by J.R. Prentice in the US as the American Breeders Service in 1941 selling the semen of cattle.^[4] In 2005 Genus acquired, through the takeover of Sygen International plc, PIC, a company founded by six pork producers in the UK as the Pig Improvement Company in 1962.^[5]

Board of Directors

• Bob Lawson (Chairman).^[1]
• Karim Bitar (CEO).^[1]
• Stephen Wilson (Group Finance Director).^[1]
• Nigel Turner (Senior Non-Executive Director).^[1]
• Mike Buzzacott (Non-Executive Director).^[1]
• Professor Duncan Maskell (Non-Executive Director).^[1]
• Lykele van der Broek (Non-Executive Director).^[1]
• Dan Hartley (Group General Counsel & Company Secretary).^[1]

Operations

The Company has two divisions:

• ABS - products for cattle
• PIC - products for pigs

References

1. "Genus plc - Investor Relations - Genus Board". genusplc.com. Retrieved 28 March 2015.
2. "Preliminary Results 2015". Genus plc. Retrieved 9 April 2016.
3. The BSE Inquiry
4. ABS Global Parent Reports Positive Year-End Results and Stock Listing
5. "Genus Completes Acquisition Of Sygen". The Pig Site. Retrieved 28 March 2015.

External links

• Official site